Modifying Writer and Eraser Enzymes Reverses Neurodevelopmental Disorders in Mice

Mouse models of two rare brain development disorders see their conditions corrected through manipulation of histone H3K4me.

2:36 PM

Author | Kelly Malcom

drawing of gene on notebook paper
Image by Stephanie King.

Normal brain development occurs in part through a process called histone methylation, which controls the expression of the genetic code written in DNA. One of these histones, called H3K4me, is found extensively throughout the brains of mammals, including humans. Errors in the methylation of H3K4me can cause neurodevelopmental disorders and intellectual disabilities. In a new study, Shigeki Iwase, Ph.D., Natalie Tronson, Ph.D. and their team have shown how these errors—and their corresponding memory and behavioral deficits— may be corrected in an animal.

"Mutations in many H3K4me enzymes are responsible for neurodevelopmental disorders. Yet, we do very little about how these mutations lead to brain malfunctions," says Iwase, associate professor in the U-M Medical School's department of human genetics. "Determining the functional relationship between H3K4me enzymes, therefore, is an essential first step for therapeutics of these conditions."

By manipulating so-called writer and eraser enzymes that control the methylation of H3K4me, they for the first time, reversed abnormal brain cell structure and aggressive behaviors in mouse models of two rare neurodevelopmental syndromes, Wiedemann-Steiner Syndrome and Claes-Jensen syndrome. The findings hint at the potential therapeutic promise of altering enzymes that control histone methylation in humans.

Paper cited: "Mutually suppressive roles of KMT2A and KDM5C in behaviour, neuronal structure, and histone H3K4 methylation," Communications BiologyDOI: 10.1038/s42003-020-1001-6

More Articles About: Lab Notes Basic Science and Laboratory Research Developmental Delay Retardation Genetic Disorders All Research Topics
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]


Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Featured News & Stories cells colorful
Health Lab
Improvements in human genome databases offer a promising future for cancer research
A gene sequencing method called ribosome profiling has expanded our understanding of the human genome by identifying previously unknown protein coding regions. Also known as Ribo-seq, this method allows researchers to get a high-resolution snapshot of protein production in cells.
flies moving sled in snow with person
Health Lab
Gene links exercise endurance, cold tolerance and cellular maintenance in flies
A study in PNAS identifies a protein that, when missing, makes exercising in the cold that much harder—that is, at least in fruit flies.
bacteria black background yellow cell
Health Lab
The surprising origin of a deadly hospital infection
Surprising findings from a Michigan Medicine study in Nature Medicine suggest that the burden of C. diff infection may be less a matter of hospital transmission and more a result of characteristics associated with the patients themselves.
cancer cell
Health Lab
Language barriers in cancer care
Research from experts at Michigan Medicine shows that significant language-based disparities exist in patients’ access to cancer care services, and it’s well before their first appointment with a doctor. 
Health Lab
Genetic mutation linked to adrenal tumor and hypertension
Research from the Department of Molecular & Integrative Physiology at Michigan Medicine identifies a previously unknown genetic mutation that causes the disease called primary aldosteronism in certain populations.
MRI scan drawing
Health Lab
Whole-body MRIs aren't as beneficial as they seem
While it's tempting to know what's going on inside your entire body, a clinical perspective piece, written by a radiologist at the University of Michigan, discusses some of the harms of imaging low risk patients, such as overdiagnosis, overtreatment and their related complications